Evidence map›Paper›PMID 40531372›Full record

ArticleEndocrine pathology2025

A Novel Three-Stage AI-Assisted Approach for Accurate Differential Diagnosis and Classification of NIFTP and Thyroid Neoplasms.

Shweta Birla, Nimisha Tiwari, Pragati Shyamal, Abhishek Khatri, Divya Bandaru, Arundhati Sharma, Dinesh Gupta, Shipra Agarwal

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shweta Birla *Translational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067, India.ORCID http://orcid.org/0000-0003-3869-9606
Nimisha Tiwari *Translational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067, India.
Pragati Shyamal *Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India.
Abhishek KhatriTranslational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067, India.
Divya BandaruTranslational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067, India.
Arundhati SharmaDepartment of Anatomy, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India.ORCID http://orcid.org/0000-0003-1920-7768
Dinesh GuptaTranslational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067, India. dinesh@icgeb.res.in.ORCID http://orcid.org/0000-0002-7548-8835
Shipra AgarwalDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India. drshipra0902@gmail.com.ORCID http://orcid.org/0000-0001-7037-4444

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/PR34211/AI/133/1/2019
6 · The paper itself

Abstract

The recent introduction of the term non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) marked a pivotal shift in the classification of encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC) lacking invasive features. While its reclassification from the "malignant" to "low-risk neoplasm" category significantly reduced overtreatment, its histopathological diagnosis remains challenging due to overlapping features with other thyroid lesions and inter-observer variability. Artificial intelligence (AI) overcomes such key limitations of histopathological evaluation, ensuring a robust and efficient diagnostic process. While preliminary studies are promising, AI models capable of efficiently distinguishing NIFTP from other benign and malignant thyroid entities are yet to be developed. We devised an innovative AI-based three-stage hierarchical pipeline that systematically evaluates architectural patterns and nuclear features. The prioritized models were trained using 154,498 patches, derived from 134 sections prepared from 125 thyroid nodules, representing follicular nodular disease (FND), follicular adenoma, dominant nodule in FND, invasive EFVPTC (IEFVPTC), and classic and infiltrative follicular subtypes of PTC. External validation revealed good accuracy at the overall, patient-wise, and class-wise levels. However, it showed limitations in the differential diagnosis of NIFTP from IEFVPTC-an expected challenge due to overlapping nuclear features and the absence of incorporating the assessment of the tumor capsule for invasive characteristics. While the novel approach and the algorithm show promise in transforming histopathological NIFTP diagnostics, further improvements and rigorous validations are necessary before considering its application in real-world clinical settings.

Indexed as

Adenocarcinoma, FollicularArtificial IntelligenceThyroid Cancer, PapillaryThyroid NeoplasmsDiagnosis, DifferentialFemaleHumansArtificial intelligenceDeep learningDifferential diagnosisDigital pathologyNIFTPThyroid

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.